检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:俞受程[1] 张伟京[1] 邓春江[1] 阎安文 马恩普 刘淑珍 苏航[1] 鲍云华[1]
机构地区:[1]解放军第307医院肿瘤科
出 处:《上海医学》1996年第10期590-594,共5页Shanghai Medical Journal
摘 要:对3组共20例恶性淋巴瘤病人进行自身外周血干细胞回输,采用三种不同的动员剂和治疗方案:1.皮质激素动员;口服强的松或静注地塞米松可使收集浓聚的白细胞明显增多,为给药前自身血的4.bl倍和7.24倍。2.硫酸葡聚糖(DS)动员:10%葡萄糖液9~10ml+N,S.100ml静滴,在外周血干细胞高峰期进行分离,其WBC,MNC和CFU-GM分别为使用前的2.04倍、4.14倍和2.04倍。3.G-CSF或CTX+G-CSF动员:平均分离2.6次总数可获得WBC15.47×l0 ̄9、MNC13.89×l0 ̄9、CFU-GM25.4×l0 ̄5、13.24×l0 ̄7。临床应用:1.激素动员组化疗采用CTX+VCR,分别输入2,11×10 ̄9和2.40×l0 ̄9,其中CFU-C产率为0.72×l0 ̄5和0.33×l0 ̄5,可以加速造血恢复。2.DS动员组化疗采用CHVP方案,输入自身干细胞MNC5.5×l0 ̄9、CFU-GM1.54×l0 ̄5。输后14天白细胞(WBC)恢复至4×l0 ̄9/L以上,PT在输后16天恢复至照前水平。3.G-CSF或CTX+G-CSF动员组化疗采用CHVP方案或超大剂量化疗(BCNU+VP-?0 cases malignant lymphoma were divided into three groups which patients reinfusedautologous peripheral stem cells and adopted three kinds of mobilized agent and chemo-thera-peutic scheme,1.Hormone Group:Using pred.or dexamethasone,WBC was increased significantly. It was 4. 6l and 7.24 fold compared with pre-mobilization,After chemotherapy(CTX+VCR),MNC(2.11×109and2.40×109)andCFU-GM(0.7×105 nd 0.33×105)wasreinfused.It hastened hemopoietic reconstitution,2.Dextron sulfate(DS)Group:10%DS9~10ml+N.S. 100ml I.V.The WBC,MNC and CFU-GM was 2.04,4.14 and 2.04 fold respectively compared with pre-mobilization. After chemotherapy(CHVP),the total MNC(5.5 × 109)and CFU-GM(1.54 × l05) was refused.WBC recovered more than 4× l09/L in14 days,while Pt was in l6 days at normal level.3.G-CSF or CTX+G-CSF Group:Afterhigh dose chemotherapy or super high dose chemotherapy(CHVP or BCNU + Vp-l6 +CTX),thetotal WBC(15.47×109),MNC(13.89×109),CFU-GM(25.4×105),cells(13.24× 107)was reinfused.WBC recovered more than 2.2×109/L in l6 days,wmkPt was50×109/L in l9 days. It was an ideal stem cell mobilized agent and satisfactory effect for tu-mour remission.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15